A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
for Acute HIV Infection
32 locations incl. Birmingham
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All·Age: 18 - 70
Code: NCT05719441·Phase 2·Recruiting